Prime Medicine develops gene editing therapies for genetic diseases. Its products and services include therapeutic research, treatment development, and platform technology for patients, healthcare providers, and biopharmaceutical partners.
Prime Medicine products and services overview:
Revenue: ~$5 million
Employees: 180
Headquarters: Cambridge, United States (USA)
Prime Medicine is one of the...
Prime Medicine is a company listed under the stock ticker PRME (US).
View the org chart displaying its 24 main executives
Create your alert
to follow the executive moves at Prime Medicine.
Prime Medicine has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.